Current methods available for pre-implantation genetic diagnosis (PGD) of in vitro fertilized (IVF) embryos do not detect de novo. Detection of these types of mutations requires whole genome sequencing (WGS). In this study advanced massively parallel WGS was performed on three 5-10 cell biopsies from two blastocyst-stage embryos. Overall, greater than 95% of each genome was called and experimentally derived haplotypes and barcoded read data were used to detect and phase up to 82% of de novo single base mutations with a false positive rate of ~1 error per Gb. These results suggest that phased WGS using barcoded DNA could be used in the future as part of the PGD process to maximize comprehensiveness in detecting disease causing mutations and reduce the incidence of genetic diseases.

Whole Genome Sequencing and Haplotyping of Blastocyst Biopsies

Fertilization in Vitro study with SNP/CNV Genotypes (NGS) data on dbGaP (6 participants)

Whole Genome Sequencing and Haplotyping of Blastocyst Biopsies

Description

Applying For Access

Summary